PropertyValue
?:definition
  • Molecular assay reagents intended to identify mutations in the majority of genes known to be associated with lysosomal storage disorders, a collection of metabolic disorders associated with deficiencies in lysosomal function, which lead to the accumulation of various metabolites normally processed in these organelles. Genetic variants at multiple loci have been associated with lysosomal storage disorders. These reagents are intended to detect mutations in the majority of lysosomal storage disorders-associated loci simultaneously.
?:hasCUIAnnotation
?:hasGeneratedBy
?:type

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/C4286284_UMD>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/C4286284_UMD>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all